Alternatively, ABT-737 has been reported to potentiate the TRAIL-induced apoptosis of human pancreatic cancer cells by conformationally changing Bax and disrupting the binding of Bak with Bcl-xL [43]. The gene discussed is BAX; the disease is familial pancreatic carcinoma.